Cargando…

When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics

Stroke prevention with oral anticoagulants in patients with atrial fibrillation predisposes for bleeding. As a result, in select patient groups anticoagulation is withheld because of a perceived unfavorable risk-benefit ratio. Reasons for withholding anticoagulation can vary greatly between clinicia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seelig, Jaap, Pisters, Ron, Hemels, Martin E, Huisman, Menno V, ten Cate, Hugo, Alings, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755244/ https://www.ncbi.nlm.nih.gov/pubmed/31571891 http://dx.doi.org/10.2147/VHRM.S187656

Ejemplares similares

New-onset atrial fibrillation during critical illness: another piece of the puzzle
por: Seelig, Jaap, et al.
Publicado: (2022)

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
por: Chu, G., et al.
Publicado: (2020)

Adherence to anticoagulation: an ongoing challenge
por: Seelig, J., et al.
Publicado: (2019)

New oral anticoagulants: discussion on monitoring and adherence should start now!
por: ten Cate, Hugo
Publicado: (2013)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
por: Seelig, J., et al.
Publicado: (2020)

Screening over 100 000 patients in 39 general practices in the Netherlands for anticoagulation underprescription in atrial fibrillation: a descriptive, cross-sectional study
por: Voorhout, Leonard, et al.
Publicado: (2023)

Emergency department presentations because of atrial fibrillation: too many, too soon
por: Pisters, R., et al.
Publicado: (2021)

Drug-induced notched T waves
por: de Vries, T. A. C., et al.
Publicado: (2021)

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation
por: Seelig, J, et al.
Publicado: (2022)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
por: van der Horst, Sabine F. B., et al.
Publicado: (2023)

Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board
por: Mulder, B. A., et al.
Publicado: (2020)

Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
por: Seelig, Jaap, et al.
Publicado: (2020)

Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
por: Zanaty, Mario, et al.
Publicado: (2020)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

The proof for new oral anticoagulants: clinical trial evidence
por: Huisman, Menno V.
Publicado: (2011)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

Is it safe to withhold long-term anticoagulation therapy in patients with small pulmonary emboli diagnosed by SPECT scintigraphy?
por: Ghazvinian, R., et al.
Publicado: (2016)

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation
por: Chu, Gordon, et al.
Publicado: (2020)

Withdrawing may be preferable to withholding
por: Vincent, Jean-Louis
Publicado: (2005)

Withholding and withdrawing in real life
por: Piazza, O
Publicado: (2019)

Giving or Withholding Fluid and Nutrients
por: Smithard, David G
Publicado: (1999)

On the ethics of withholding and withdrawing medical treatment
por: Reichlin, Massimo
Publicado: (2014)

Withholding the Annual Report: An Explanation Asked for
Publicado: (1916)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Zielinski, Gilda Denise, et al.
Publicado: (2019)

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2019)

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Zielinski, Gilda D., et al.
Publicado: (2021)

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world
por: Kozieł, Monika, et al.
Publicado: (2021)

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2022)

Withdrawing and withholding life-sustaining therapies are not the same
por: Levin, Phillip D, et al.
Publicado: (2005)

The withholding/withdrawing distinction in the end-of-life debate
por: Sanchini, Virginia, et al.
Publicado: (2014)

Withholding and canceling a response in ADHD adolescents
por: Bhaijiwala, Mehereen, et al.
Publicado: (2014)

Withdrawing and Withholding Life-Prolonging Medical Treatment
por: Jessiman, Ian
Publicado: (2000)

To withhold resuscitation – The Swedish system’s rules and challenges
por: Piscator, Eva, et al.
Publicado: (2023)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Introduction to topic discussions
por: Chiggiato, Paolo
Publicado: (2023)

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
por: Bayer, Valentina, et al.
Publicado: (2022)

Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion
por: Martin, Anne-Céline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ms3sdbm1a1uh8f5okh2bhmg4v